Linked research, clinical, and regulatory source pathways.
Company profile
About Shenzhen Mindray Bio-Medical Electronics Co.,LTD
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is a leading global medical device manufacturer that develops, manufactures, and markets a comprehensive range of medical equipment and solutions. Founded in Shenzhen, China, Mindray has established a significant presence in North America and worldwide, serving healthcare facilities across the continuum of care. The company's product portfolio spans multiple critical healthcare domains including patient monitoring systems (BeneVision N-Series), ultrasound imaging (Resona and Hepatus series), anesthesia workstations (A-Series), ventilators (SV-Series), in vitro diagnostics, and surgical tables. Mindray's patient monitoring solutions range from high-acuity continuous monitoring to telemetry and vital signs systems, featuring advanced interoperability through BeneLink and robust cybersecurity measures. Their ultrasound division offers specialized systems for general imaging, liver and gastroenterology care, women's health, and point-of-care applications, incorporating innovative technologies like Visualized Transient Elastography (ViTE) and Liver Ultrasound Attenuation (LiSA). The company's anesthesia and ventilation products serve critical care, perioperative, and out-of-hospital settings. Mindray emphasizes clinical education, technical support, and comprehensive service programs to support healthcare providers. The company maintains strategic partnerships with major healthcare organizations like Medtronic and serves diverse customer segments including health systems, ambulatory surgery centers, and private practices across multiple geographic markets.
Company description Shenzhen Mindray Bio-Medical Electronics Co.,LTD official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- anesthesia
- cardiology
- critical care
- gastroenterology
- hepatology
- respiratory care
- women's health
Who it serves
- Ambulatory Surgery Centers
- Critical Care Facilities
- Health Systems
- Hospitals
- Private Practices
Deployment & integration
Deployment information is currently being developed.
Recorded integration context: BeneLink, DICOM, eGateway.
Geographic context
Company milestones
Platform expansion
Launched Resona A20 ultra premium ultrasound at RSNA 2025; Introduced TE Air e5M wireless handheld ultrasound (November 2025); Expanded Hepatus-Series ultrasound systems (June 2026); Entered ventilator market with SV-Series (March 2026); Expanded partnership with Medtronic to ambulatory surgery centers (January 2026); Broke ground on major warehouse expansion (June 2025)
Partnerships
Recorded partners
- Medtronic
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
No source-backed Company products are currently listed.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Corrigendum to Neural network model outperforms conventional equations in LDL cholesterol estimation: A comparative study of 188,887 Chinese individuals with focus on hypertriglyceridemia [Atherosclerosis Plus, (62), December 2025, Pages 38-46].Atherosclerosis plus · Mar 1, 2026
Neural network model outperforms conventional equations in LDL cholesterol estimation: A comparative study of 188,887 Chinese individuals with focus on hypertriglyceridemia.Atherosclerosis plus · Dec 1, 2025
Distribution characteristics and screening reference values of NT-proBNP in high cardiovascular risk population.Nutrition, metabolism, and cardiovascular diseases : NMCD · Aug 1, 2025
Respiratory effort monitoring: a novel, bedside, non-invasive, real-time method.Critical care (London, England) · Jul 3, 2025
Transcriptome dynamics of the BHK21 cell line in response to human coronavirus OC43 infection.Microbiological research · Aug 1, 2024
Clinical validation
Clinical-trial records
Multicenter Clinical Study on Noninvasive Assessment of Hepatic Steatosis and Fibrosis Using Visual Transient ElastographyNCT07128108 · Sponsor · RECRUITING
Regulatory
Regulatory records
TEX20/TEX20 Pro/TEX20S/TEX20T/TEX20 Exp/TEX20 Elite Diagnostic Ultrasound System, TEX10/ TEX10 Pro/TEX10S/TEX10T/TEX10 Exp/TEX10 Elite/TE X/TE X Lite Diagnostic Ultrasound SystemK212265 · 510k · Nov 16, 2021
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
gastroenterology and hepatology care with ViTE and LiSA integration
automated measurements and AI-powered smart tools
advanced anesthesia workstation technology
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Shenzhen Mindray Bio-Medical Electronics Co.,LTD
Recent articles published on Shenzhen Mindray Bio-Medical Electronics Co.,LTD's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.